Introduction {#sec1}
============

The expansion of the medicinal chemistry-relevant chemical space requires cost- and time-effective synthetic methods for producing diverse molecules from readily available starting materials (commonly called building blocks).^[@ref1]^ Recently, synthetic chemists more often considered multicomponent reactions (MCRs) for this purpose.^[@ref2]^ The reason is the elaboration of new methodologies and expansion of the scope and limitations of MCR, which lead to the products bearing functional groups. The Castagnoli--Cushman reaction (CCR), i.e., the reaction of imines (I) with cyclic anhydrides (II, IV), is one of the most popular in this view ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref3]^

![Castagnoli--Cushman Reaction](ao0c02394_0006){#sch1}

This reaction is an efficient tool for the synthesis of various lactams, which have the carboxyl function, and is widely used in the preparation of combinatorial libraries^[@ref4]^ as well as the synthesis of building blocks.^[@cit4a],[@ref5]^ In recent years, a significant number of papers devoted to the problem of the use of different anhydrides in CCR were published,^[@ref6]^ and only a few ones dealt with the expansion of the scope of carbonyl and amino components.^[@ref7]^ On the other hand, the fluorine atom is one of the most prominent in drugs and agrochemicals.^[@ref8]^ The trifluoromethyl group is one of the most represented among the fluorine-containing compounds. This popular structural motif occurs in more than seventy approved drugs.^[@ref9]^ Therefore, the expansion of the scope of CCR to trifluoroacetaldehyde, which could lead to the formation of new 2-trifluoromethyl-substituted 5-oxo-pyrrolidine, 6-oxo-piperidine, and 7-oxo-azepine3-carboxylic acids, was an exciting task.

In our ongoing research on the scope of CCR,^[@cit4a],[@cit5a]^ as well as the methods for the efficient synthesis of trifluoromethyl-containing building blocks,^[@ref10]^ we examined azomethines based on trifluoroacetaldehyde as a substrate.

Results and Discussion {#sec2}
======================

In this work, we describe the possibility of using azomethines based on trifluoroacetaldehyde in CCR for the production of diverse 2-trifluoromethyl-substituted 3-pyrrolidine- and 3-piperidine carboxylic acids. The previously described anhydrides were used as starting materials.^[@cit4a]^ We successfully scaled up the known methodology for obtaining Schiff bases from fluoral hydrate to gram quantities. In the first step, we used molecular sieves as a dehydrating agent for the reaction of fluoral hydrate **1** with amines **2**. Then, the final Schiff base **4** was formed from hemiaminal intermediate **3** in boiling toluene using a catalytic amount of PTSA and a Dean--Stark trap ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref11]^ The crude products were purified by vacuum distillation.

![Synthesis of Schiff Bases](ao0c02394_0007){#sch2}

In the first step of our research, azomethine **4a** (*R* = *p*-methoxybenzyl (PMB)) and succinic (**5a**), glutaric (**6a**), and homophthalic (**7a**) anhydrides were selected as model compounds. These substrates were examined in our standard conditions for CCR, elaborated earlier. The mixture of Schiff base and anhydride was boiled in xylenes (140 °C, 5--24 h) ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Unfortunately, only for homophthalic anhydride **7a**, the desired product **10a** was formed with good conversion (73%). The structure and trans stereochemistry of the derivative **10a** were proven by X-ray single-crystal diffraction studies ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref12]^

![X-ray diffraction patterns of (3*R*\*,4*R*\*)-2-(4-methoxybenzyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid **10a**.](ao0c02394_0002){#fig1}

![4-Methoxy-*N*-(2,2,2-trifluoroethylidene)benzylamine in CCR with Model Anhydrides in Standard Conditions](ao0c02394_0008){#sch3}

###### Optimization of Reaction Conditions of **4a** + **5a** and **4a** + **6a**([@ref13])

  no.   anhydride   solvent   conditions         result (**18a** by LCMS, %)
  ----- ----------- --------- ------------------ -----------------------------
  2     **5a**      NMP       160 °C, 6 h        7 (24 h)
  3     **5a**      Ph~2~O    160 °C, 6 h        12
  6     **5a**      Ph~2~O    200 °C, 6 h        12
  8     **5a**      xylenes   MW (200 °C), 1 h   3

  no.   anhydride   solvent         conditions         result (**17a** by LCMS, %)
  ----- ----------- --------------- ------------------ -----------------------------
  9     **6a**      DMA             140 °C, 6 h         
  12    **6a**      Ph~2~O          180 °C, 6 h        21 (24 h)
  15    **6a**      sulfolane       200 °C, 6 h         
  16    **6a**      xylenes         MW (200 °C), 1 h    
  17    **6a**      Ph~2~O          MW (300 °C), 1 h   11
  20    **6a**      NMP             MW (225 °C), 1 h   15
  21    **6a**      Ph~2~O          225 °C, 6 h        52
  22    **6a**      NMP             200 °C, 6 h        12
  24    **6a**      Ph~2~O          MW (250 °C), 1 h   52
  28    **6a**      Ph~2~O          275 °C, 6 h         
  30    **6a**      Ph~2~O, 1.0 M   225 °C, 6 h        57
  32    **6a**      Ph~2~O, 4.0 M   225 °C, 6 h        55

In the cases of **5a** and **6a**, only monoamides **12a** and **14a** were detected, respectively, after 24 h of heating as major products. These results are consistent with our previous ones^[@cit5a]^ and with the research of Bakulina and co-workers^[@cit4f]^ and could be explained by lower reactivity of the zwitterion intermediate in the cases of **5a** and **6a** compared to that in **7a** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Side Products in CCR with Succinic (**5a**) and Glutaric (**6a**) Anhydrides](ao0c02394_0009){#sch4}

Therefore, the optimization of reaction conditions was needed. Temperature, solvent, heating type, and reaction time were varied, and the conversion was measured by liquid chromatography--mass spectrometry (LCMS); the data are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

As can be seen from the table, the product with appropriate molecular weight for anhydride **5a** did not form in any reaction condition. In most cases, the product **18a** was the main compound detected, which formed as a result of CCR between anhydride **5a** and intermediate **16a** (the result of imine metathesis between **11a** and **15a**). On the other hand, for anhydride **6a**, we detected a product with a relevant peak in LCMS. However, a more detailed analysis of its structure showed that the isomeric product **17a** formed as a result of \[1,3\]-H shift of the starting azomethine. The structure of this product was proven by NMR spectra (4.65 (dq, *J* = 15.3, 10.0 Hz, 1H) and 3.08 (dq, *J* = 15.2, 9.0 Hz, 1H) signals were observed that corresponded to diastereotopic protons of the CH~2~CF~3~ group) and by the counter synthesis ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). All our attempts for reaction condition optimization to form **8a** and **9a** led only to **18a** and **17a**, respectively.

![Proposed Pathway for the Formation of **17a** and **18a**](ao0c02394_0010){#sch5}

To explain these data, we proposed the pathway shown in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}. Schiff base **4a** undergoes a \[1,3\]-hydride shift under thermal conditions and forms another azomethine **15a**. The latter reacts with a 6-membered anhydride and forms **17a** but does not do the same with a 5-membered one. Meanwhile, **15a** could react with the intermediate **11a** and transform it into another acylated imine **16a** as a result of imine exchange. We determined that azomethine **4a** could transform to **15a** under reaction conditions without anhydride added.^[@ref14]^

However, the imine exchange was not observed in the absence of anhydride in the reaction mixture (RM), and imine metathesis occurred only in the presence of acid.^[@ref15]^

The formation of **17a** and **18a** also has been proven by the counter synthesis based on azomethines **15a** and **15b** and appropriate anhydrides in the reaction conditions ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}).

![Counter Synthesis of Derivatives **17a** and **18a**](ao0c02394_0011){#sch6}

Such behavior was general for 5- and 6-membered cyclic anhydrides. Compounds **5b** and **6b** with different acidity of α-methylene groups ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}) were examined in the reaction at optimized conditions. The same results, the formation of acids **18b** and **17b**, respectively, were observed.

![Formation of Derivatives **17b** and **18b**](ao0c02394_0012){#sch7}

Next, we carried out the reaction of succinic (**5a**) or glutaric (**6a**) anhydrides with trifluoroethylidene methanamines **4b** and **4c** to finalize our attempts to direct CCR to the formation of targeted 2-trifluoromethyl-substituted 5-oxo-pyrrolidine or 6-oxo-piperidine-3-carboxylic acids. Their selection was governed by the impossibility to have the \[1,3\]-H shift in these substrates. Unfortunately, in such cases, no target or side products were observed. A complex mixture of the decomposition and polymerization products was formed ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

![Schiff bases **4a**--**h**, which were explored in CCR.](ao0c02394_0003){#fig2}

After such unsuccessful attempts to obtain CCR products from aliphatic 5- and 6-membered cyclic anhydrides, we focused our attention on homophthalic anhydride (**7a**) and its homologue adipic anhydride with an annelated benzene ring (**19a**). Similarly to aliphatic 5- and 6-membered cyclic anhydrides, we tried different conditions of CCR with these substrates. It was found that boiling in toluene for 6 h was the best condition for **7a** (entry 7), whereas for **19a**, it was boiling in xylene for 8 h (entry 9). The protocol of optimization is shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.

###### Optimization of Conditions for the Formation of **10a** and **20a**([@ref13])

  no.   anhydride   solvent   conditions    result (**10a** by LCMS, %)
  ----- ----------- --------- ------------- -----------------------------
  1     **7a**      DMA       140 °C, 6 h    
  2     **7a**      xylene    140 °C, 6 h   73
  3     **7a**      CHCl~3~   RT, 6 h       67
  4     **7a**      MeCN      RT, 6 h       68
  5     **7a**      DCE       80 °C, 6 h    77
  6     **7a**      MeCN      80 °C, 6 h    54
  7     **7a**      toluene   110 °C, 6 h   92
  8     **7a**      DMA       110 °C, 6 h    

  no.   anhydride   solvent   conditions    result (**20a** by LCMS, %)
  ----- ----------- --------- ------------- -----------------------------
  9     **19a**     xylene    140 °C, 8 h   49
  10    **19a**     toluene   110 °C, 8 h   30

Once the optimal conditions were chosen, we studied CCR of **7a** and **19a** with a series of Schiff bases **4a**, **4c**--**h**. All of the target products **10a**, **10c**--**h**, and **20a**, **20c**--**h** were obtained in moderate to good yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Afterward, we made an attempt to remove the PMB protecting group from amides **10a** and **20a**. Unfortunately, only trace amounts of the desired products **21** and **22** were detected in the reaction mixture using different standard procedures for the debenzylation of the PMB group, even after 70 h of stirring at room temperature (rt). Increasing the temperature to 80 °C for 16 h led to higher conversion (23% for **21** and 53% for **22** by LCMS data).

###### Structures and Yields of Compounds **10a**,**c**--**h** and **20a**,**c**--**h**

![](ao0c02394_0014){#fx1}

However, at the same time, it led to the partial destruction of the products and to increase in the number and quantity of impurities. Thus, unprotected amide was obtained messy enough and the method looked unsuitable for multigram-scale synthesis. In contrast to PMB, the DMB protecting group could be deprotected in such conditions more clearly. The appropriate conditions for the deprotection of compounds **10h** (trifluoroacetic acid, TFA, 16 h, reflux) and **20h** (TFA, 70 h, rt), which led to target acids, were found. The acids **21** and **22** were obtained on 10 gram scales ([Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}).

![Synthetic Potential of CCR Based on Fluoral Hydrate](ao0c02394_0013){#sch8}

The structure and trans stereochemistry of the derivative **20a** were proven by X-ray single-crystal diffraction studies ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).^[@ref16]^

![X-ray diffraction patterns of (1*R*\*,2*R*\*)-3-(4-methoxybenzyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-benzo\[*d*\]azepine-1-carboxylic acid **20a**.](ao0c02394_0004){#fig3}

Conclusions {#sec3}
===========

In conclusion, the reactivity of azomethines based on trifluoroacetaldehyde hydrate in a Castagnoli--Cushman reaction was investigated. It was shown that an acceptor substituent such as the trifluoromethyl group remarkably decreased the reactivity of azomethines in CCR. Nevertheless, the procedures for using trifluoroethylidene methanamines in the reaction with the most active anhydrides of homophthalic and benzannelated adipic acids were elaborated. These procedures became suitable for the multigram synthesis of building blocks, as demonstrated in the synthesis of (3*R*\*,4*R*\*)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid and (1*R*\*,2*R*\*)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-benzo\[*d*\]azepine-1-carboxylic acid with preparative yields (54--55%) and good trans diastereoselectivity in 10 gram scales. Unexpected results were obtained after using succinic and glutaric anhydrides in CCR. These results allowed us to arrange anhydrides by the activity ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Therefore, the reaction with fluoral hydrate can be used for the determination of the activity of anhydrides in CCR. The reasons for such results and possible pathways of their formation have been discussed. It was shown that the unusual products formed as a result of the \[1,3\]-H shift and imine metathesis, which could happen in the reaction conditions. It is very important for the understanding of possible mechanisms of CCR and can open the door for their more detailed investigation.

![Relative activity of anhydrides in CCR.](ao0c02394_0005){#fig4}

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

The solvents were purified according to the standard procedures. All starting materials were obtained from Enamine Ltd. Melting points were measured on an automated melting point system. ^1^H, ^13^C, and ^19^F NMR spectra were recorded on a Bruker 170 Avance 500 spectrometer (at 500 MHz for protons and 126 MHz for carbon-13) and a Varian Unity Plus 400 spectrometer (at 400 MHz for protons, 101 MHz for carbon-13, and 376 MHz for fluorine-19). Tetramethylsilane (^1^H, ^13^C) or C~6~F~6~ (^19^F) were used as standards. Elemental analyses were performed at the Laboratory of Organic Analysis, Institute of Organic Chemistry, National Academy of Sciences of Ukraine, and their results were found to be in good agreement (±0.4%) with the calculated values. Preparative high-performance liquid chromatography (HPLC) analyses were done on an Agilent 1200 system. Mass spectra were recorded on an Agilent 1100 LCMSD SL instrument (chemical ionization (APCI)). CCDC-1986046 (**10a**) and CCDC-1986047 (**20a**) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via [www.ccdc.cam.ac.uk/data_request/cif](www.ccdc.cam.ac.uk/data_request/cif).

Experimental Data and Analytical Data for Synthesized Compounds {#sec4.2}
---------------------------------------------------------------

### General Procedure A {#sec4.2.1}

A solution of amine (0.1 mol) in dichloromethane (DCM) (300 mL) was added to fluoral hydrate 75% in H~2~O (23.15 g; 0.15 mol). Then, 3A molecular sieves (50 g) were added. After 24 h, molecular sieves were filtered off and washed two times with DCM. The filtrate was evaporated. The residue was dissolved in toluene (300 mL). *p*-Toluenesulfonic acid monohydrate (344 mg; 1.8 mmol) was added. The reaction mixture was refluxed with a Dean--Stark trap for 16 h. Then, the reaction mixture was cooled to room temperature and the precipitate was filtered off. The filtrate was evaporated, and the residue was purified by distillation.

#### 4-Methoxy-*N*-(2,2,2-trifluoroethylidene)benzylamine (**4a**) {#sec4.2.1.1}

Scaled to 0.108 mol; colorless liquid; yield 87% (20.3 g). ^**1**^**H NMR** (400 MHz, chloroform-*d*) δ 7.53--7.63 (m, 1H), 7.17 (d, *J* = 8.4 Hz, 2H), 6.90 (d, *J* = 8.5 Hz, 2H), 4.75 (s, 2H), 3.79 (s, 3H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 159.3, 149.7 (q, *J* = 38.1 Hz), 129.7, 128.0, 119.0 (q, *J* = 274.6 Hz), 114.3, 62.8, 55.3. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.0. EIMS, 70 eV, *m*/*z* (rel. int.): 217 \[M\]^+^ (14); 122 (9); 121 (100); 78 (11); 77 (10). Anal. calcd for C~10~H~10~F~3~NO: C, 55.30; H, 4.64; N, 6.45. Found: C, 55.47; H, 4.25; N, 6.74.

#### 2-Phenyl-*N*-2,2,2-trifluoroethylidenepropan-2-amine (**4b**) {#sec4.2.1.2}

Scaled to 14.4 mmol; colorless liquid; yield 73% (2.27 g); bp = 67--69 °C (*P* = 7.8 mbar). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.45 (q, *J* = 3.2 Hz, 1H), 7.43--7.35 (m, 4H), 7.31 (tt, *J* = 6.4, 1.8 Hz, 1H), 1.67 (s, 6H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 146.4 (q, *J* = 38.1 Hz), 144.8, 128.6, 127.2, 126.0, 119.6 (q, *J* = 275.0 Hz), 64.0, 28.9. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −71.8. EIMS, 70 eV, *m*/*z* (rel. int.): 215 \[M\] + (1); 159 (27); 120 (10); 119 (100); 109 (17); 91 (46); 77 (12). Anal. calcd for C~11~H~12~F~3~N: C, 61.39; H, 5.62; N, 6.51. Found: C, 61.04; H, 5.80; N, 6.74.

#### 4-Methoxy-*N*-2,2,2-trifluoroethylideneaniline (**4c**) {#sec4.2.1.3}

Scaled to 43.1 mmol; colorless liquid; yield 71% (6.18 g); bp = 92--93 °C (*P* = 7.8 mbar). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.82 (q, *J* = 3.6 Hz, 1H), 7.28 (d, *J* = 8.8 Hz, 2H), 6.93 (d, *J* = 8.9 Hz, 2H), 3.83 (d, 3H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 160.5, 144.0 (q, *J* = 38.5 Hz), 139.9, 123.2, 119.6 (q, *J* = 273.7 Hz), 114.6, 55.4. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −71.2. EIMS, 70 eV, *m*/*z* (rel. int.): 203 \[M\]^+^ (71); 134 (100); 107 (25); 92 (19); 77 (26); 64 (13); 63 (11). Anal. calcd for C~9~H~8~F~3~NO: C, 53.21; H, 3.97; N, 6.89. Found: C, 53.44; H, 3.97; N, 7.17.

#### 1-Phenyl-*N*-2,2,2-trifluoroethylidenemethanamine (**4d**) {#sec4.2.1.4}

Scaled to 0.108 mol; colorless liquid; yield 82% (16.6 g). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.70--7.63 (m, 1H), 7.42 (t, *J* = 7.2 Hz, 2H), 7.36 (t, *J* = 7.2 Hz, 1H), 7.31 (d, *J* = 7.2 Hz, 2H), 4.84 (s, 2H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 150.1 (q, *J* = 38.2 Hz), 136.2, 128.9, 128.3, 127.9, 119.0 (q, *J* = 274.7 Hz), 63.5. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.0. EIMS, 70 eV, *m*/*z* (rel. int.): 187 \[M\]^+^ (12); 106 (10); 91 (100); 65 (10). Anal. calcd for C~9~H~8~F~3~N: C, 57.76; H, 4.31; N, 7.48. Found: C, 57.45; H, 4.10; N, 7.22.

#### 1-Thiophen-2-yl-*N*-2,2,2-trifluoroethylidenemethanamine (**4e**) {#sec4.2.1.5}

Scaled to 21.5 mmol; pale yellow liquid; yield 32% (1.33 g); bp = 68--69 °C (*P* = 13 mbar). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.63--7.57 (m, 1H), 7.32 (d, *J* = 5.1 Hz, 1H), 7.04 (dd, *J* = 5.1, 3.4 Hz, 1H), 6.99 (d, *J* = 3.4 Hz, 1H), 5.02 (s, 2H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 150.4 (q, *J* = 38.4 Hz), 137.5, 127.3, 127.1, 126.1, 119.0 (q, *J* = 274.7 Hz), 57.0. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.0. EIMS, 70 eV, *m*/*z* (rel. int.): 193 \[M\]^+^ (18); 97 (100). Anal. calcd for C~7~H~6~F~3~NS: C, 43.52; H, 3.13; N, 7.25; S, 16.6. Found: C, 43.85; H, 3.27; N, 7.28; S, 16.98.

#### 1-(3-Fluorophenyl)-*N*-2,2,2-trifluoroethylidenemethanamine (**4f**) {#sec4.2.1.6}

Scaled to 21.5 mmol; colorless liquid; yield 44% (1.94 g); bp = 65--70 °C (*P* = 7.6 mbar). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.74--7.65(m, 1H), 7.38--7.31 (m, 1H), 7.10--7.05 (m, 1H), 7.04--6.97 (m, 2H), 4.80 (s, 2H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 163.0 (d, *J* = 246.5 Hz), 150.6 (q, *J* = 38.3 Hz), 138.8 (d, *J* = 7.4 Hz), 130.3 (d, *J* = 8.3 Hz), 123.7 (d, *J* = 2.9 Hz), 118.8 (q, *J* = 274.7 Hz), 115.1 (d, *J* = 21.9 Hz), 114.7 (d, *J* = 21.0 Hz), 62.8 (d, *J* = 1.9 Hz). ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.2, -113.2. EIMS, 70 eV, *m*/*z* (rel. int.): 205 \[M\]^+^ (14); 124 (15); 109 (100); 83 (14). Anal. calcd for C~9~H~7~F~4~N: C, 52.69; H, 3.44; N, 6.83. Found: C, 53.07; H, 3.41; N, 6.84.

#### *N*-2,2,2-Trifluoroethylidenecyclohexanamine (**4g**) {#sec4.2.1.7}

Scaled to 21.5 mmol; colorless liquid; yield 32% (1.24 g). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.61 (q, *J* = 3.5 Hz, 1H), 3.25 (t, *J* = 10.5 Hz, 1H), 1.88--1.75 (m, 2H), 1.74--1.62 (m, 3H), 1.51 (qd, *J* = 12.4, 3.4 Hz, 2H), 1.39--1.27 (m, 2H), 1.29--1.17 (m, 1H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 147.0 (q, *J* = 37.9 Hz), 118.9 (q, *J* = 274.7 Hz), 68.6, 33.3, 25.2, 24.2. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.3. EIMS, 70 eV, *m*/*z* (rel. int.): 178 \[M--H\] (3); 160 (12); 151 (12); 150 (100); 136 (48); 110 (55); 83 (83); 82 (15); 67 (17); 55 (76); 54 (25); 53 (10); 41 (35); 39 (18). Anal. calcd for C~8~H~12~F~3~N: C, 53.62; H, 6.75; N, 7.82. Found: C, 54.02; H, 7.00; N, 7.86.

#### 1-(2,4-Dimethoxyphenyl)-*N*-2,2,2-trifluoroethylidenemethanamine (**4h**) {#sec4.2.1.8}

Scaled to 500 mmol; colorless liquid; yield 80% (98.4 g); bp = 85--87 °C (*P* = 0.6 mbar). ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 7.51 (s, 1H), 7.12 (d, *J* = 7.9 Hz, 1H), 6.52--6.46(m, 2H), 4.78 (s, 2H), 3.81 (s, 3H), 3.79 (s, 3H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 161.0, 158.7, 149.6 (q, *J* = 37.8 Hz), 131.1, 119.2 (q, *J* = 274.5 Hz), 116.4, 104.4, 98.6, 57.8, 55.3, 55.2. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −72.0. EIMS, 70 eV, *m*/*z* (rel. int.): 247 \[M\]^+^ (16); 152 (10); 151 (100); 121 (38); 91 (12); 77 (10). Anal. calcd for C~11~H~12~F~3~NO~2~: C, 53.44; H, 4.89; N, 5.67. Found: C, 53.49; H, 4.51; N, 5.68.

#### Synthesis of 2,2,2-Trifluoro-*N*-(4-methoxyphenyl)methylideneethanamine (**15a**) {#sec4.2.1.9}

4-Methoxybenzaldehyde (3.134 g; 23.0 mmol) was mixed with 2,2,2-trifluoroethan-1-amine hydrochloride (6.193 g; 46.0 mmol) in toluene (65 mL). Then, triethylamine (4.66 g; 46.0 mmol) and p-toluenesulfonic acid monohydrate (79 mg; 0.42 mmol) were added. The reaction mixture was refluxed with the Dean--Stark trap for 16 h. Then, more 2,2,2-trifluoroethan-1-amine hydrochloride (3.1 g; 23.0 mmol) and triethylamine (2.33 g; 23.0 mmol) were added. The reaction mixture (RM) was refluxed with the Dean--Stark trap for additional 16 h. Then, the RM was cooled to RT. The precipitate was filtered off and washed with toluene. The filtrate was evaporated. The residue was distilled in vacuo to give 3.22 g of the product as a colorless liquid. Yield = 64%. ^**1**^**H NMR** (500 MHz, chloroform-*d*) δ 8.27 (s, 1H), 7.74 (d, *J* = 8.2, 2H), 6.95 (d, *J* = 8.1 Hz, 2H), 4.09 (q, *J* = 9.4, 2H), 3.86 (s, 3H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 166.0, 162.5, 130.3, 128.2, 124.8 (q, *J* = 277.2 Hz), 114.1, 61.4 (q, *J* = 30.5 Hz), 55.2. ^**19**^**F NMR** (376 MHz, chloroform-*d*) δ −71.5. EIMS, 70 eV, *m*/*z* (rel. int.): 217 \[M\]^+^ (12); 217 \[M\]^+^ (100); 216 (35); 148 (50); 133 (21); 121 (84); 91 (14); 77 (13). Anal. calcd for C~10~H~10~F~3~NO: C, 55.30; H, 4.64; N, 6.45. Found: C, 55.16; H, 4.36; N, 6.72.

Synthesis of Side Products {#sec4.3}
--------------------------

### General Procedure B {#sec4.3.1}

4-Methoxy-*N*-(2,2,2-trifluoroethylidene)benzylamine (for **17a**,**b** and **18a**,**b**) or 2,2,2-trifluoro-*N*-(4-methoxyphenyl)methylideneethanamine (for 2-(4-methoxyphenyl)-5-oxo-1-(2,2,2-trifluoroethyl)pyrrolidine-3-carboxylic acid) (1.50 mmol) was dissolved in diphenyl ether (375 mcl), and anhydride (1.50 mmol) was added. The reaction mixture was heated to 225 °C (oil bath) in an argon atmosphere for 6 h. Then, it was cooled to room temperature and was purified by preparative HPLC (MeCN/H~2~O mobile phase).

#### (2*R*\*,3*R*\*)-1-(4-Methoxybenzyl)-2-(4-methoxyphenyl)-5-oxopyrrolidine-3-carboxylic Acid (**18a**) {#sec4.3.1.1}

White crystals; yield 16% (44 mg); mp = 120--121 °C. ^**1**^**H NMR** (500 MHz, DMSO-*d*~6~) δ 12.64 (br, 1H), 7.12 (d, *J* = 8.6 Hz, 2H), 6.95 (d, *J* = 8.9 Hz, 2H), 6.92 (d, *J* = 8.9 Hz, 2H), 6.84 (d, *J* = 8.6 Hz, 2H),4.75 (d, *J* = 14.9 Hz, 1H), 4.44 (d, *J* = 5.9 Hz, 1H), 3.76 (s, 3H), 3.72 (s, 3H), 3.33 (d, *J* = 14.9 Hz, 1H), 3.01 (dt, *J* = 9.7, 6.7 Hz, 1H), 2.80 (dd, *J* = 17.0, 9.7 Hz, 1H), 2.58 (dd, *J* = 16.9, 7.2 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 174.3, 172.5, 159.6, 158.9, 131.7, 129.5, 128.9, 128.5, 114.7, 114.3, 63.3, 55.6, 55.5, 46.0, 43.3, 33.8. LCMS, positive mode, *m*/*z*: 356 \[M + H\]^+^. Anal. calcd for C~20~H~21~NO~5~: C, 67.59; H, 5.96; N, 3.94. Found: C, 67.77; H, 5.94; N, 4.18.

#### (2*R*\*,3*R*\*)-5-(4-Methoxybenzyl)-4-oxo-6-(4-methoxyphenyl)-5-azaspiro\[2.4\]heptane-7-carboxylic Acid (**18b**) {#sec4.3.1.2}

Pale yellow crystals; yield 28% (82 mg); mp = 160--161 °C. ^**1**^**H NMR** (500 MHz, DMSO-*d*~6~) δ 12.73 (s, 1H), 7.15 (d, *J* = 8.6 Hz, 2H), 6.99 (d, *J* = 8.6 Hz, 2H), 6.96 (d, *J* = 8.6 Hz, 2H), 6.85 (d, *J* = 8.6 Hz, 2H), 4.80 (d, *J* = 15.0 Hz, 1H), 4.62 (d, *J* = 4.9 Hz, 1H), 3.76 (s, 3H), 3.73 (s, 3H), 3.43 (d, *J* = 15.1 Hz, 1H), 2.91 (d, *J* = 4.8 Hz, 1H), 1.22--1.11 (m, 1H), 1.06--0.96 (m, 1H), 0.96--0.82 (m, 2H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 174.3, 172.9, 159.6, 158.9, 131.7, 129.5, 128.8, 128.5, 114.9, 114.3, 61.2, 55.6, 55.5, 52.1, 43.9, 25.3, 13.9, 11.0. LCMS, positive mode, *m*/*z*: 382 \[M + H\]^+^. Anal. calcd for C~22~H~23~NO~5~: C, 69.28; H, 6.08; N, 3.67. Found: C, 68.92; H, 6.40; N, 4.03.

#### (2*R*\*,3*R*\*)-2-(4-Methoxyphenyl)-6-oxo-1-(2,2,2-trifluoroethyl)piperidine-3-carboxylic Acid (**17a**) {#sec4.3.1.3}

White crystals; yield 20% (100 mg); mp = 155--156 °C. ^**1**^**H NMR** (500 MHz, DMSO-*d*~6~) δ 12.76 (s, 1H), 7.15 (d, *J* = 8.4 Hz, 2H), 6.96 (d, *J* = 8.6 Hz, 2H), 5.00 (d, *J* = 5.4 Hz, 1H), 4.65 (dq, *J* = 15.3, 10.0 Hz, 1H), 3.76 (s, 3H), 3.08 (dq, *J* = 15.2, 9.0 Hz, 1H), 2.91--2.80 (m, 1H), 2.68--2.52 (m, 2H), 1.98--1.75 (m, 2H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 173.6, 170.4, 159.4, 131.5, 128.6, 125.1 (q, *J* = 281.3 Hz), 114.7, 63.0, 55.6, 46.8, 44.7 (q, *J* = 32.9 Hz), 30.0, 20.4. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −67.8. LCMS, positive mode, *m*/*z*: 332 \[M + H\]^+^. Anal. calcd for C~15~H~16~F~3~NO~4~: C, 54.38; H, 4.87; N, 4.23. Found: C, 54.04; H, 4.89; N, 4.01.

#### (2*R*\*,3*R*\*)-5,5-Difluoro-2-(4-methoxyphenyl)-6-oxo-1-(2,2,2-trifluoroethyl)piperidine-3-carboxylic Acid (**17b**) {#sec4.3.1.4}

Pale brownish crystals; yield 36% (196 mg); mp = 155--156 °C. ^**1**^**H NMR** (500 MHz, DMSO-*d*~6~) δ 13.07 (s, 1H), 7.17 (d, *J* = 8.6 Hz, 2H), 7.00 (d, *J* = 8.6 Hz, 2H), 5.23--5.05 (m, 1H), 4.65--4.40 (m, 1H), 3.76 (s, 3H), 3.62--3.47 (m, 1H), 3.44--3.28 (m, 1H), 3.13--3.03 (m, 1H), 2.83--2.66 (m, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 171.7, 162.3 (t, *J* = 30.4 Hz), 159.8, 129.2, 128.9, 124.6 (q, *J* = 281.4 Hz), 115.0, 112.1 (t, *J* = 243.5 Hz), 63.0, 55.6, 45.5 (q, *J* = 33.6 Hz), 44.1, 31.5 (t, *J* = 23.4 Hz). ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −67.3, −97.7. LCMS, positive mode, *m*/*z*: 368 \[M + H\]^+^. Anal. calcd for C~15~H~14~F~5~NO~4~: C, 49.05; H, 3.84; N, 3.81. Found: C, 49.37; H, 3.91; N, 3.47.

Synthesis of (3*R*\*,4*R*\*)-3-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acids {#sec4.4}
--------------------------------------------------------------------------------------------------

### General Procedure C {#sec4.4.1}

The Schiff base (2.00 mmol) and homophthalic anhydride (324 mg; 2.00 mmol) were mixed in toluene (6 mL), and the reaction mixture was heated to 110 °C in an argon atmosphere. It was refluxed for 6 h and then cooled to room temperature.

#### (3*R*\*,4*R*\*)-2-(4-Methoxybenzyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10a**) {#sec4.4.1.1}

The product was obtained by filtration and recrystallized from (*i*-Pr)~2~O/MeOH; white crystals; yield 65% (494 mg); mp = 203--204 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.31 (s, 1H), 7.92 (d, *J* = 7.7 Hz, 1H), 7.55 (t, *J* = 7.3 Hz, 1H), 7.50--7.40 (m, 2H), 7.27 (d, *J* = 8.3 Hz, 2H), 6.86 (d, *J* = 8.4 Hz, 2H), 5.20 (d, *J* = 14.8 Hz, 1H), 5.00 (q, *J* = 7.6 Hz, 1H), 4.37 (s, 1H), 4.24 (d, *J* = 14.7 Hz, 1H), 3.73 (s, 3H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 170.8, 163.2, 159.0, 133.8, 132.7, 130.2, 129.7, 129.1, 128.5, 128.2, 125.7 (q, *J* = 286.7 Hz), 127.5, 114.0, 58.7 (q, *J* = 29.1 Hz), 55.4, 50.5, 42.7. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −71.9. LCMS, positive mode, *m*/*z*: 380 \[M + H\]^+^. Anal. calcd for C~19~H~16~F~3~NO~4~: C, 60.16; H, 4.25; N, 3.69. Found: C, 60.17; H, 3.91; N, 3.66.

#### (3*R*\*,4*R*\*)-2-(4-Methoxyphenyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10c**) {#sec4.4.1.2}

Purified by prep. HPLC (MeCN/H~2~O mobile phase); pale brownish crystals; yield 53% (387 mg); mp = 108--109 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.60 (br, 1H), 7.92 (d, *J* = 7.5 Hz, 1H), 7.68--7.55 (m, 2H), 7.49 (td, *J* = 7.5, 1.6 Hz, 1H), 7.35 (d, *J* = 8.8 Hz, 2H), 7.02 (d, *J* = 8.8 Hz, 2H), 5.30 (q, *J* = 7.5 Hz, 1H), 4.48 (s, 1H), 3.79 (s, 3H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 171.1, 162.6, 158.6, 134.8, 133.9, 133.1, 129.7, 129.0, 128.8, 128.2, 128.0, 125.5 (q, *J* = 286.5 Hz), 114.6, 61.6 (q, *J* = 28.2 Hz), 55.8, 42.9. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −71.3. LCMS, positive mode, *m*/*z*: 366 \[M + H\]^+^. Anal. calcd for C~18~H~14~F~3~NO~4~: C, 59.18; H, 3.86; N, 3.83. Found: C, 59.44; H, 3.56; N, 3.58.

#### (3*R*\*,4*R*\*)-2-Benzyl-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10d**) {#sec4.4.1.3}

Scaled to 20 mmol; the product was obtained by filtration; yellow crystals; yield 53% (3.71 g); mp = 189--190 °C. ^**1**^**H NMR** (500 MHz, DMSO-*d*~6~) δ 13.34 (br, 1H), 7.91 (d, *J* = 7.7 Hz, 1H), 7.57 (t, *J* = 7.5 Hz, 1H), 7.48 (d, 8.3 Hz), 7.45 (t, 7.5 Hz), 7.36--7.22 (m, 5H), 5.16 (d, *J* = 15.1 Hz, 1H), 5.06 (q, *J* = 7.7 Hz, 1H), 4.46--4.33 (m, 2H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 170.9, 163.3, 137.4, 134.0, 132.8, 129.7, 128.6, 128.5, 128.4, 128.0, 127.6, 127.5, 125.7 (q, *J* = 286.4 Hz), 59.3 (q, *J* = 28.8 Hz), 51.6, 42.8. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.0. LCMS, positive mode, *m*/*z*: 350 \[M + H\]^+^. Anal. calcd for C~18~H~14~F~3~NO~3~: C, 61.89; H, 4.04; N, 4.01. Found: C, 62.25; H, 3.77; N, 3.65.

#### (3*R*\*,4*R*\*)-1-oxo-2-(Thiophen-2-ylmethyl)-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10e**) {#sec4.4.1.4}

The product was obtained by filtration; yellow crystals; yield 52% (370 mg); mp = 196--197 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.33 (br, 1H), 7.93 (d, *J* = 7.7 Hz, 1H), 7.56 (t, *J* = 7.4 Hz, 1H), 7.49--7.44 (m, 2H), 7.44--7.40 (m, 1H), 7.15 (d, *J* = 3.5 Hz, 1H), 6.94 (t, *J* = 4.3 Hz, 1H), 5.31 (d, *J* = 15.2 Hz, 1H), 5.13 (q, *J* = 7.6 Hz, 1H), 4.59 (d, *J* = 15.2 Hz, 1H), 4.38 (s, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 170.7, 163.0, 139.2, 134.0, 132.8, 129.7, 128.5, 128.1, 128.0, 127.5, 126.8, 126.7, 125.6 (q, *J* = 286.2 Hz), 58.7 (q, *J* = 29.4 Hz), 46.14, 42.8. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.2. LCMS, positive mode, *m*/*z*: 356 \[M + H\]^+^. Anal. calcd for C~16~H~12~F~3~NO~3~S: C, 54.08; H, 3.40; N, 3.94; S, 9.02. Found: C, 54.39; H, 3.53; N, 3.96; S, 9.21.

#### (3*R*\*,4*R*\*)-2-(3-Fluorobenzyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10f**) {#sec4.4.1.5}

Purified by prep. HPLC (MeCN/H~2~O mobile phase); pale brownish crystals; yield 63% (463 mg); mp = 149--150 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.46 (br, 1H), 7.91 (d, *J* = 7.6 Hz, 1H), 7.57 (t, *J* = 7.1 Hz, 1H), 7.50 (d, *J* = 7.6 Hz, 1H), 7.45 (t, *J* = 7.5 Hz, 1H), 7.33 (q, *J* = 7.0 Hz, 1H), 7.23--7.12 (m, 2H), 7.06 (td, *J* = 8.6, 2.6 Hz, 1H), 5.19 (q, *J* = 7.5 Hz, 1H), 5.13 (d, *J* = 15.2 Hz, 1H), 4.47 (d, *J* = 15.3 Hz, 1H), 4.41 (s, 1H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 171.0, 163.4, 162.6 (d, *J* = 242.8 Hz), 140.6 (d, *J* = 7.3 Hz), 134.1, 132.9, 130.4 (d, *J* = 8.2 Hz), 129.8, 128.6, 127.9, 127.5, 125.7 (q, *J* = 287.2 Hz), 124.5, 115.1 (d, *J* = 21.7 Hz), 114.3 (d, *J* = 20.8 Hz), 59.5 (q, *J* = 29.1 Hz), 51.4, 42.9. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.1, −114.1. LCMS, positive mode, *m*/*z*: 368 \[M + H\]^+^. Anal. calcd for C~18~H~13~F~4~NO~3~: C, 58.86; H, 3.57; N, 3.81. Found: C, 58.88; H, 3.84; N, 3.79.

#### (3*R*\*,4*R*\*)-2-Cyclohexyl-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10g**) {#sec4.4.1.6}

Purified by prep. HPLC (MeCN/H~2~O mobile phase); white crystals; yield 52% (355 mg); mp = 139--140 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.37 (br, 1H), 7.83 (d, *J* = 7.6 Hz, 1H), 7.52 (t, *J* = 7.4 Hz, 1H), 7.48--7.34 (m, 2H), 4.99 (q, *J* = 7.7 Hz, 1H), 4.32 (s, 1H), 3.77 (tt, *J* = 11.8, 3.6 Hz, 1H), 2.08--1.92 (m, 1H), 1.88--1.66(m, 5H), 1.66--1.54 (m, 1H), 1.40--1.20 (m, 2H), 1.19--1.03 (m, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 171.0, 163.2, 133.4, 132.4, 129.5, 129.1, 128.4, 127.4, 125.4 (q, *J* = 285.9 Hz), 60.2, 58.0 (q, *J* = 29.3 Hz), 43.6, 29.9, 29.7, 26.3, 26.1, 25.6. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −71.1. LCMS, positive mode, *m*/*z*: 342 \[M + H\]^+^. Anal. calcd for C~17~H~18~F~3~NO~3~: C, 59.82; H, 5.32; N, 4.10. Found: C, 59.59; H, 5.10; N, 3.92.

#### (3*R*\*,4*R*\*)-2-(2,4-Dimethoxybenzyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**10h**) {#sec4.4.1.7}

Scaled to 150 mmol; the product was obtained by filtration; white crystals; yield 62% (37.95 g); mp = 224--225 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.16 (s, 1H), 7.91 (d, *J* = 8.4 Hz, 1H), 7.54 (t, *J* = 7.5, 1H), 7.47--7.40 (m, 2H), 7.11 (d, *J* = 8.3 Hz, 1H), 6.53 (d, *J* = 2.4 Hz, 1H), 6.44 (dd, *J* = 8.3, 2.4 Hz, 1H), 5.21 (d, *J* = 14.7 Hz, 1H), 4.90 (q, *J* = 7.7 Hz, 1H), 4.33 (s, 1H), 4.16 (d, *J* = 14.7 Hz, 1H), 3.75 (s, 3H), 3.74 (s, 3H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 170.7, 162.9, 160.7, 158.9 133.8, 132.6, 131.4, 128.5, 128.2, 127.5, 125.9 (q, *J* = 286.7 Hz), 116.5, 104.9, 98.7, 58.2 (q, *J* = 29.2 Hz), 55.8, 55.6, 45.3, 42.6. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.1. LCMS, negative mode, *m*/*z*: 408 \[M--H\]^−^. Anal. calcd for C~20~H~18~F~3~NO~5~: C, 58.68; H, 4.43; N, 3.42. Found: C, 58.78; H, 4.12; N, 3.26.

Synthesis of (1*R*\*,2*R*\*)-2-(Trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acids {#sec4.5}
---------------------------------------------------------------------------------------------------------

### General Procedure D {#sec4.5.1}

The Schiff base (2.00 mmol) and 1,5-dihydro-3-benzoxepine-2,4-dione (352 mg; 2.00 mmol) were mixed in xylene (6 mL), and the reaction mixture was heated to 140 °C in an argon atmosphere. It was refluxed for 8 h and then cooled to room temperature.

#### (1*R*\*,2*R*\*)-3-(4-Methoxybenzyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20a**) {#sec4.5.1.1}

The product was obtained by filtration and recrystallized from (*i*-Pr)~2~O/MeOH; pale brownish crystals; yield 43% (338 mg); mp = 225--226 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.58 (s, 1H), 7.34 (s, 3H), 6.99--6.87 (m, 1H), 6.53 (d, *J* = 8.1 Hz, 2H), 6.34 (d, *J* = 8.1 Hz, 2H), 5.12 (d, *J* = 15.4 Hz, 1H), 4.81--4.69 (m, 1H), 4.64 (d, *J* = 9.5 Hz, 1H), 4.19 (d, *J* = 14.3 Hz, 1H), 3.85 (d, *J* = 15.5 Hz, 1H), 3.64 (s, 3H), 3.49 (d, *J* = 14.4 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.3, 171.9, 158.6, 136.8, 132.3, 128.8, 128.4, 128.4, 128.4, 128.1, 126.9, 126.4 (q, *J* = 286.6 Hz), 113.9, 60.0 (q, *J* = 27.6 Hz), 55.4, 50.8, 47.5, 42.1. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.8. LCMS, positive mode, *m*/*z*: 394 \[M + H\]^+^. Anal. calcd for C~20~H~18~F~3~NO~4~: C, 61.07; H, 4.61; N, 3.56. Found: C, 60.95; H, 4.52; N, 3.31.

#### (1*R*\*,2*R*\*)-3-(4-Methoxyphenyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20c**) {#sec4.5.1.2}

Purified by prep. HPLC (MeCN/H~2~O mobile phase); pale brownish crystals; yield 4% (31 mg); mp = 188--189 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.64 (br, 1H), 7.41--7.29 (m, 3H), 7.25 (d, *J* = 7.4 Hz, 1H), 6.88 (d, *J* = 8.5 Hz, 2H), 6.79 (d, *J* = 8.5 Hz, 2H), 5.15 (p, *J* = 7.7 Hz, 1H), 4.72 (d, *J* = 8.6 Hz, 1H), 4.12 (d, *J* = 15.1 Hz, 1H), 3.75 (d, *J* = 15.1 Hz, 1H), 3.71 (s, 3H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 172.4, 171.0, 158.5, 136.9, 136.0, 132.8, 129.2, 129.0, 128.8, 128.4, 128.3, 125.6 (![](ao0c02394_0016.jpg){#igr1}, *J* = 285.2 Hz), 114.6, 64.7 (q, *J* = 28.4 Hz), 55.8, 48.7, 42.8. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −70.8. LCMS, positive mode, *m*/*z*: 380 \[M + H\]^+^. Anal. calcd for C~19~H~16~F~3~NO~4~: C, 60.16; H, 4.25; N, 3.69. Found: C, 60.27; H, 4.31; N, 3.45.

#### (1*R*\*,2*R*\*)-3-Benzyl-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20d**) {#sec4.5.1.3}

Scaled to 20 mmol; the product was obtained by filtration; white crystals; yield 32% (2.34 g); mp = 211--212 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.63 (s, 1H), 7.36 (s, 3H), 7.08 (t, *J* = 7.5 Hz, 1H), 7.04--6.91 (m, 3H), 6.39 (d, *J* = 7.5 Hz, 2H), 5.17 (d, *J* = 15.8 Hz, 1H), 4.80 (p, *J* = 8.0 Hz, 1H), 4.68 (d, *J* = 9.4 Hz, 1H), 4.22 (d, *J* = 14.4 Hz, 1H), 3.99 (d, *J* = 15.8 Hz, 1H), 3.50 (d, *J* = 14.4 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.3, 172.0, 136.9, 136.9, 132.4, 128.8, 128.5, 128.5, 128.2, 127.4, 126.9, 126.9, 126.3 (q, *J* = 286.2 Hz), 60.6 (q, *J* = 27.3 Hz), 51.5, 47.5, 42.1. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.9. LCMS, positive mode, *m*/*z*: 364 \[M + H\]^+^. Anal. calcd for C~19~H~16~F~3~NO~3~: C, 62.81; H, 4.44; N, 3.86. Found: C, 62.57; H, 4.56; N, 3.85.

#### (1*R*\*,2*R*\*)-4-oxo-3-(Thiophen-2-ylmethyl)-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20e**) {#sec4.5.1.4}

The product was obtained by filtration and recrystallized from (*i*-Pr)~2~O/MeOH; pale brownish crystals; yield 30% (222 mg); mp = 217--218 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.60 (br, 1H), 7.35--7.25 (m, 3H), 7.20 (d, *J* = 5.1 Hz, 1H), 6.93 (d, *J* = 6.9 Hz, 1H), 6.74 (t, *J* = 4.3 Hz, 1H), 6.54 (d, *J* = 3.5 Hz, 1H), 5.24 (d, *J* = 15.6 Hz, 1H), 4.91 (p, *J* = 7.5 Hz, 1H), 4.61 (d, *J* = 9.4 Hz, 1H), 4.22 (d, *J* = 15.6 Hz, 1H), 4.15 (d, *J* = 14.4 Hz, 1H), 3.49 (d, *J* = 14.4 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.2, 171.4, 139.0, 136.4, 132.1, 128.6, 128.5, 128.0, 127.0, 126.6, 126.5, 126.3, 126.2 (q, *J* = 286.2 Hz), 60.1 (q, *J* = 27.4 Hz), 47.5, 47.1, 42.0. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −72.9. LCMS, positive mode, *m*/*z*: 370 \[M + H\]^+^. Anal. calcd for C~17~H~14~F~3~NO~3~S: C, 55.28; H, 3.82; N, 3.79; S, 8.68. Found: C, 55.46; H, 3.68; N, 4.07; S, 8.45.

#### (1*R*\*,2*R*\*)-3-(3-Fluorobenzyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20f**) {#sec4.5.1.5}

The product was obtained by filtration and recrystallized from (*i*-Pr)~2~O/MeOH; white crystals; yield 24% (183 mg); mp = 226--227 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.67 (s, 1H), 7.45--7.29 (m, 3H), 7.12--6.99(m, 2H), 6.89 (td, *J* = 8.5, 2.6 Hz, 1H), 6.36 (d, *J* = 7.6 Hz, 1H), 6.03 (d, *J* = 10.3 Hz, 1H), 5.12 (d, *J* = 16.0 Hz, 1H), 4.85 (p, *J* = 8.0 Hz, 1H), 4.70 (d, *J* = 9.4 Hz, 1H), 4.22 (d, *J* = 14.4 Hz, 1H), 4.08 (d, *J* = 16.0 Hz, 1H), 3.50 (d, *J* = 14.4 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.3, 172.0, 163.4, 162.4 (d, *J* = 243.4 Hz), 140.2 (d, *J* = 7.2 Hz), 136.8, 132.3, 130.3 (d, *J* = 8.2 Hz), 128.8, 128.6, 128.3, 126.9, 126.3 (q, *J* = 285.8 Hz), 122.9 (d, *J* = 2.7 Hz), 114.1 (d, *J* = 20.9 Hz), 113.2 (d, *J* = 22.1 Hz), 61.0 (q, *J* = 27.4 Hz), 51.3, 47.5, 42.0. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −73.1, −113.9. LCMS, positive mode, *m*/*z*: 382 \[M + H\]^+^. Anal. calcd for C~19~H~15~F~4~NO~3~: C, 59.85; H, 3.97; N, 3.67. Found: C, 59.99; H, 3.84; N, 3.54.

#### (1*R*\*,2*R*\*)-3-Cyclohexyl-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20g**) {#sec4.5.1.6}

Purified by prep. HPLC (MeCN/H~2~O mobile phase); gray crystals; yield 15% (109 mg); mp = 217--218 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.75 (br, 1H), 7.39--7.19 (m, 3H), 7.10--6.96 (m, 1H), 4.87 (p, *J* = 7.9 Hz, 1H), 4.58 (d, *J* = 8.1 Hz, 1H), 4.06 (d, *J* = 14.2 Hz, 1H), 3.78 (tt, *J* = 11.9, 3.5 Hz, 1H), 3.39 (d, *J* = 14.2 Hz, 1H), 1.77--1.61 (m, 1H), 1.61--1.42 (m, 3H), 1.40--1.25 (m, 1H), 1.28--1.09 (m, 2H), 1.10--0.86 (m, 2H), 0.60 (d, *J* = 12.0 Hz, 1H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 173.1, 172.6, 136.8, 132.3, 128.7, 128.4, 128.1, 126.9, 125.8 (q, *J* = 284.6 Hz), 59.0, 57.2 (q, *J* = 28.3 Hz), 48.4, 43.1, 30.8, 30.1, 25.9, 25.8, 25.3. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −71.9. LCMS, positive mode, *m*/*z*: 356 \[M + H\]^+^. Anal. calcd for C~18~H~20~F~3~NO~3~: C, 60.84; H, 5.67; N, 3.94. Found: C, 60.50; H, 5.41; N, 3.96.

#### (1*R*\*,2*R*\*)-3-(2,4-Dimethoxybenzyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**20h**) {#sec4.5.1.7}

Scaled to 200 mmol; the product was obtained by filtration and recrystallized from (*i*-Pr)~2~O; white crystals; yield 37% (31.6 g); mp = 245--246 °C. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.55 (s, 1H), 7.33--7.17 (m, 3H), 6.95 (d, *J* = 6.0 Hz, 1H), 6.35--6.23 (m, 2H), 6.10 (dd, *J* = 8.4, 2.3 Hz, 1H), 4.99--4.85 (m, 2H), 4.59 (d, *J* = 9.5 Hz, 1H), 4.13 (d, *J* = 14.4 Hz, 1H), 3.82 (d, *J* = 15.3 Hz, 1H), 3.65 (s, 3H), 3.46 (s, 3H), 3.39 (d, *J* = 14.4 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.4, 171.5, 160.4, 158.5, 136.9, 132.2, 130.2, 128.5, 128.3, 127.8, 126.6, 126.5 (q, *J* = 286.4 Hz), 116.3, 104.1, 98.3, 60.2 (q, *J* = 27.1 Hz), 55.5, 55.4, 47.7, 47.5, 42.1. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −73.1. LCMS, negative mode, *m*/*z*: 422 \[M--H\]^−^. Anal. calcd for C~21~H~20~F~3~NO~5~: C, 59.57; H, 4.76; N, 3.31. Found: C, 59.61; H, 4.40; N, 3.55.

#### Preparation of (3*R*\*,4*R*\*)-1-oxo-3-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid (**21**) {#sec4.5.1.8}

(3*R*\*,4*R*\*)-2-(2,4-Dimethoxybenzyl)-1-oxo-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid (**10h**) (30.00 g; 73.2 mmol) was dissolved in trifluoroacetic acid (300 mL; 3.93 mol). The reaction mixture was heated to 80 °C (oil bath) and was refluxed for 16 h. Then, the solvent was removed in vacuo. The residue was evaporated with toluene (2 × 300 mL). Then, it was purified by column chromatography (CombiFlash MeCN/H~2~O mobile phase C18) to give 10.47 g of product as pale yellow crystals (mp = 166--167 °C). Yield = 55%. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.39 (s, 1H), 8.76 (d, *J* = 5.5 Hz, 1H), 7.86 (d, *J* = 7.5 Hz, 1H), 7.56 (t, *J* = 7.4 Hz, 1H), 7.50 (d, *J* = 7.4 Hz, 1H), 7.43 (t, *J* = 7.5 Hz, 1H), 4.71--4.59 (m, 1H), 4.32 (s, 1H). ^**13**^**C NMR** (126 MHz, chloroform-*d*) δ 171.1, 163.6, 134.3, 132.8, 129.9, 128.5, 127.9, 127.2, 125.4 (q, *J* = 284.2 Hz), 53.3 (q, *J* = 30.5 Hz), 42.0. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −75.0. LCMS, positive mode, *m*/*z*: 260 \[M + H\]^+^. Anal. calcd for C~11~H~8~F~3~NO~3~: C, 50.98; H, 3.11; N, 5.40. Found: C, 51.33; H, 3.06; N, 5.64.

#### Preparation of (1*R*\*,2*R*\*)-4-oxo-2-(Trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic Acid (**22**) {#sec4.5.1.9}

(1*R*\*,2*R*\*)-3-(2,4-Dimethoxybenzyl)-4-oxo-2-(trifluoromethyl)-2,3,4,5-tetrahydro-1*H*-3-benzazepine-1-carboxylic acid (**20h**) (30.00 g; 70.8 mmol) was dissolved in trifluoroacetic acid (300 mL; 3.93 mol). The reaction mixture was stirred for 70 h at room temperature. Then, the solvent was removed in vacuo. The residue was evaporated with toluene (2 × 300 mL). Then, it was purified by column chromatography (CombiFlash MeCN/H~2~O mobile phase C18) to give 10.5 g of product as white crystals (mp= 246--247 °C). Yield = 54%. ^**1**^**H NMR** (400 MHz, DMSO-*d*~6~) δ 13.45 (s, 1H), 7.99 (d, *J* = 5.4 Hz, 1H), 7.33--7.25 (m, 3H), 7.25--7.20 (m, 1H), 4.79--4.67(m, 1H), 4.44 (d, *J* = 9.1 Hz, 1H), 3.74 (d, *J* = 15.1 Hz, 1H), 3.68 (d, *J* = 15.1 Hz, 1H). ^**13**^**C NMR** (126 MHz, DMSO-*d*~6~) δ 172.3, 172.2, 135.5, 132.8, 129.7, 129.3, 128.6, 128.0, 125.4 (q, *J* = 283.5 Hz), 55.5 (q, *J* = 28.5 Hz), 47.9, 42.3. ^**19**^**F NMR** (376 MHz, DMSO-*d*~6~) δ −74.3. LCMS, positive mode, *m*/*z*: 274 \[M + H\]^+^. Anal. calcd for C~12~H~10~F~3~NO~3~: C, 52.75; H, 3.69; N, 5.13. Found: C, 52.72; H, 3.48; N, 5.30.
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